Pharmacologically privileged 1,4-dihydropyridine (DHP) framework is a common playground of
synthetic and medicinal chemists. Despite its widely general applicability popular Hantzsch
methodology for the construction of this novel heterocyclic moiety suffers from limitations like long
reaction time and poor yield of the product. Circumvention of these problems mainly relies on
employment of a plethora of catalysis for improvement of the reaction. Objective of this mini review
is to critically highlight the salient aspects of such catalysis during the past two decades.